Hypomethylation-mediated upregulation of the WASF2 promoter region correlates with poor clinical outcomes in hepatocellular carcinoma

Abstract Background Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide. Wiskott–Aldrich syndrome protein family member 2 (WASF2) is an integral member of the actin cytoskeleton pathway, which plays a crucial role in cell motility. In this study, we aimed to explore...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Hye Ri Ahn, Geum Ok Baek, Moon Gyeong Yoon, Ju A Son, Jung Hwan Yoon, Jae Youn Cheong, Hyo Jung Cho, Ho Chul Kang, Jung Woo Eun, Soon Sun Kim
פורמט: Artigo
שפה:Inglês
יצא לאור: BMC 2022-04-01
סדרה:Journal of Experimental & Clinical Cancer Research
נושאים:
Carcinogenesis
Liver neoplasms
DNA methylation
Prognosis
WASF2
גישה מקוונת:https://doi.org/10.1186/s13046-022-02365-7
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים